The effects of sex on pharmacogenetically guided drug treatment-Reference-Cited by-同舟云学术

The effects of sex on pharmacogenetically guided drug treatment

Published:2021-10 Issue:15 Volume:22 Page:959-962
ISSN:1462-2416
Container-title:Pharmacogenomics
language:en
Short-container-title:Pharmacogenomics

Author:

Mezzalira Silvia¹^ORCID,Toffoli Giuseppe¹^ORCID

Affiliation:

1. Experimental & Clinical Pharmacology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Via Franco Gallini 2, Aviano, 33081, Italy

Abstract

Tweetable abstract Sex-related pharmacogenetics is emerging area of research to better explain sex discrepancies in drug response. Sex pharmacogenetics should be considered an essential step for personalized medicine.

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/pgs-2021-0088

Reference20 articles.

1. Pharmacogenomics of multigenic diseases: Sex-specific differences in disease and treatment outcome

2. Sex Differences in Pharmacokinetics and Pharmacodynamics

3. The Role of the Microbiome in Drug Response

4. Sex disparity in cancer: roles of microRNAs and related functional players

5. Sex and Gender Influences on Cancer Immunotherapy Response

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opioid use disorder risk alleles in self-reported assigned African American/Afro-Caribbean and European biogeographical genetic ancestry groups and in males and females;The Pharmacogenomics Journal;2024-08

2. Characterization of Expression-Based Gene Clusters Gives Insights into Variation in Patient Response to Cancer Therapies;Cancer Informatics;2024-01

3. Sex differences in kinetic handling of various therapeutic molecules;International Journal of Pharmaceutical Chemistry and Analysis;2023-09-15

4. Pharmacogenomic variation in the Malagasy population: implications for the antimalarial drug primaquine metabolism;Pharmacogenomics;2023-07

5. Pharmacogenetic Sex-Specific Effects of Methotrexate Response in Patients with Rheumatoid Arthritis;Pharmaceutics;2023-06-05